中华肾脏病杂志
中華腎髒病雜誌
중화신장병잡지
2012年
12期
961-967
,共7页
桑珍珍%许云%盛英杰%张鹏思%孙健波%贾冬%金帅%赵敏
桑珍珍%許雲%盛英傑%張鵬思%孫健波%賈鼕%金帥%趙敏
상진진%허운%성영걸%장붕사%손건파%가동%금수%조민
红细胞生成素%脓毒症%肾功能不全,急性%盲肠结扎穿孔术
紅細胞生成素%膿毒癥%腎功能不全,急性%盲腸結扎穿孔術
홍세포생성소%농독증%신공능불전,급성%맹장결찰천공술
Erythropoietin%Sepsis%Kidney insufficiency,acute%Caecal ligation and puncture
目的 探讨重组人红细胞生成素(rHuEPO)对盲肠结扎穿孔术(CLP)所致大鼠脓毒症急性肾损伤(AKI)的保护作用.方法 260只雄性SD大鼠随机分为正常对照组、假CLP组(假手术组)、CLP组(脓毒症组)和rHuEPO大、中、小剂量组.采用CLP复制脓毒症模型,rHuEPO大、中、小剂量组造模后即刻分别静脉推注rHuEPO 5000 U/kg、1000 U/kg、500 U/kg.假CLP组、CLP组、rHuEPO大、中、小剂量组按注药后2h、6h、12 h、24 h、36 h时点分成5个亚组,分别在各时点按随机原则处死大鼠.采用ELISA法测定血清中肿瘤坏死因子α(TNF-α)、白细胞介素6(IL-6)、肾损伤分子1(KIM-1)、诱导型一氧化氮合酶(iNOS)的水平;免疫组化法检测大鼠肾组织NF-κB蛋白表达;光镜和透射电镜观察肾组织形态学变化.结果 与CLP组相比,rHuEPO大剂量组大鼠各时间点血清Scr、BUN、TNF-α、IL-6、KIM-1、iNOS的含量及肾组织NF-κB蛋白表达水平均显著降低,差异有统计学意义(P<0.05);肾脏病理改变好转.rHuEPO中、小剂量组肾脏病理改变未见好转.结论 rHuEPO能够降低脓毒症大鼠血清TNF-α、IL-6、iNOS、KIM-1水平进而调节炎性反应及肾功能,对脓毒症所致AKI具有一定的保护作用.
目的 探討重組人紅細胞生成素(rHuEPO)對盲腸結扎穿孔術(CLP)所緻大鼠膿毒癥急性腎損傷(AKI)的保護作用.方法 260隻雄性SD大鼠隨機分為正常對照組、假CLP組(假手術組)、CLP組(膿毒癥組)和rHuEPO大、中、小劑量組.採用CLP複製膿毒癥模型,rHuEPO大、中、小劑量組造模後即刻分彆靜脈推註rHuEPO 5000 U/kg、1000 U/kg、500 U/kg.假CLP組、CLP組、rHuEPO大、中、小劑量組按註藥後2h、6h、12 h、24 h、36 h時點分成5箇亞組,分彆在各時點按隨機原則處死大鼠.採用ELISA法測定血清中腫瘤壞死因子α(TNF-α)、白細胞介素6(IL-6)、腎損傷分子1(KIM-1)、誘導型一氧化氮閤酶(iNOS)的水平;免疫組化法檢測大鼠腎組織NF-κB蛋白錶達;光鏡和透射電鏡觀察腎組織形態學變化.結果 與CLP組相比,rHuEPO大劑量組大鼠各時間點血清Scr、BUN、TNF-α、IL-6、KIM-1、iNOS的含量及腎組織NF-κB蛋白錶達水平均顯著降低,差異有統計學意義(P<0.05);腎髒病理改變好轉.rHuEPO中、小劑量組腎髒病理改變未見好轉.結論 rHuEPO能夠降低膿毒癥大鼠血清TNF-α、IL-6、iNOS、KIM-1水平進而調節炎性反應及腎功能,對膿毒癥所緻AKI具有一定的保護作用.
목적 탐토중조인홍세포생성소(rHuEPO)대맹장결찰천공술(CLP)소치대서농독증급성신손상(AKI)적보호작용.방법 260지웅성SD대서수궤분위정상대조조、가CLP조(가수술조)、CLP조(농독증조)화rHuEPO대、중、소제량조.채용CLP복제농독증모형,rHuEPO대、중、소제량조조모후즉각분별정맥추주rHuEPO 5000 U/kg、1000 U/kg、500 U/kg.가CLP조、CLP조、rHuEPO대、중、소제량조안주약후2h、6h、12 h、24 h、36 h시점분성5개아조,분별재각시점안수궤원칙처사대서.채용ELISA법측정혈청중종류배사인자α(TNF-α)、백세포개소6(IL-6)、신손상분자1(KIM-1)、유도형일양화담합매(iNOS)적수평;면역조화법검측대서신조직NF-κB단백표체;광경화투사전경관찰신조직형태학변화.결과 여CLP조상비,rHuEPO대제량조대서각시간점혈청Scr、BUN、TNF-α、IL-6、KIM-1、iNOS적함량급신조직NF-κB단백표체수평균현저강저,차이유통계학의의(P<0.05);신장병리개변호전.rHuEPO중、소제량조신장병리개변미견호전.결론 rHuEPO능구강저농독증대서혈청TNF-α、IL-6、iNOS、KIM-1수평진이조절염성반응급신공능,대농독증소치AKI구유일정적보호작용.
Objective To investigate the protective effects of recombinant human erythropoietin (rHuEPO) on caecal ligation and puncture (CLP)-induced acute kidney injury (AKI).Methods A total of 260 healthy male Sprague-Dawley rats (250-300 g) were randomly divided into 6 groups:normal control group,sham group,CLP model group,the large dose rHuEPO (5000 U/kg)group,the middle dose rHuEPO (1000 U/kg) group,and the small dose rHuEPO (500 U/kg) group.The rat models of sepsis were established by CLP.In treatment groups,rats were treated with rHuEPO through caudalis injection after CLP surgery.Each group was divided into 2-,6-,12-,24-,36-hour subgroups with 10 rats.Rats were sacrificed and the tissue samples including kidney and blood samples were collected.The kidney function,plasma cytokines [interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α)],kidney injury moleclue 1 (KIM-1) and inducible nitric oxide synthase (iNOS)were measured.Cytokines were determined by ELISA method.The expression of nuclear factor-kappaB (NF-κB) protein in kidneys were detected by immnunohistochemistry method.Pathological changes of kidney tissues were observed by light and transmission electron microscopy for cytokine content and apoptosis.Results Compared with CLP model group,renal function,the levels of TNF-α,IL-6,KIM-1 and iNOS in serum,the expression of NF-κB,significantly decresed in large dose rHuEPO group (all P < 0.05).rHuEPO also lessened the histological changes in large dose group.rHuEPO did not lessen the histological changes in others.Conclusion rHuEPO can inhibit the levels of TNF-α,IL-6 and iNOS in serum,thus modify the inflammatory response and provide protective effects against acute kidney injury induced by sepsis.